Benzinga | Oct 29, 2020 06:50AM EDT

Lexicon Pharmaceuticals Q3 EPS $(0.43) Misses $0.26 Estimate, Sales $6.63M Miss $16.87M Estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $0.26 by 265.38 percent. This is a 330 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $6.63 million which missed the analyst consensus estimate of $16.87 million by 60.68 percent. This is a 97.75 percent decrease over sales of $294.45 million the same period last year.